ID: ALA5183975

Max Phase: Preclinical

Molecular Formula: C22H26N6OS

Molecular Weight: 422.56

Associated Items:

Representations

Canonical SMILES:  CC1(C)CN(c2ncnc3sc(C(=O)NCC4CCNCC4)nc23)c2ccccc21

Standard InChI:  InChI=1S/C22H26N6OS/c1-22(2)12-28(16-6-4-3-5-15(16)22)18-17-20(26-13-25-18)30-21(27-17)19(29)24-11-14-7-9-23-10-8-14/h3-6,13-14,23H,7-12H2,1-2H3,(H,24,29)

Standard InChI Key:  NQKUBPWGXDRNCR-UHFFFAOYSA-N

Associated Targets(Human)

MAP kinase signal-integrating kinase 2 3518 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

MAP kinase-interacting serine/threonine-protein kinase MNK1 2071 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Eukaryotic translation initation factor 600 Activities

Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: Topical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Properties

Molecular Weight: 422.56Molecular Weight (Monoisotopic): 422.1889AlogP: 3.25#Rotatable Bonds: 4
Polar Surface Area: 83.04Molecular Species: BASEHBA: 7HBD: 2
#RO5 Violations: 0HBA (Lipinski): 7HBD (Lipinski): 2#RO5 Violations (Lipinski): 0
CX Acidic pKa: 12.34CX Basic pKa: 10.05CX LogP: 3.15CX LogD: 0.60
Aromatic Rings: 3Heavy Atoms: 30QED Weighted: 0.67Np Likeness Score: -0.82

References

1. Xu W, Kannan S, Verma CS, Nacro K..  (2022)  Update on the Development of MNK Inhibitors as Therapeutic Agents.,  65  (2.0): [PMID:34533957] [10.1021/acs.jmedchem.1c00368]

Source